Immunocore Holdings PLC

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Immunocore Holdings PLC
TickerIMCR
CIK #0001671927
CUSIP45258D105
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address90 Park Drive Milton Park, Abingdon, Oxfordshire, OX14 4RY
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Immunocore Holdings PLC 2022-07-28 140.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001671927] 10-K
[0001671927] 10-Q
[0001671927] 3
[0001671927] 4
[0001671927] 6-K
[0001671927] 8-K
[0001671927] D
[0001671927] SC 13D
[0001671927] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vestal Point Capital LP Immunocore Holdings PLC [2026-05-15] 0.0
Bellevue Group AG Immunocore Holdings PLC [2025-11-14] 0.0
Tang Capital Management LLC Immunocore Holdings PLC [2025-10-24] 0.0
Jallal Bahija Immunocore Holdings PLC [2025-02-14] 0.0
PRIMECAP Management Co/CA/ Immunocore Holdings PLC [2025-02-13] 0.0
T Rowe Price Investment Management Inc Immunocore Holdings PLC [2024-09-10] 10.3
FMR LLC Immunocore Holdings PLC [2024-03-11] 0.0
Price T Rowe Associates Inc /MD/ Immunocore Holdings PLC [2024-02-14] 6.0
Wellington Management Group LLP Immunocore Holdings PLC [2024-02-08] 8.72
RTW Investments LP Immunocore Holdings PLC [2023-02-14] 12.3
General Atlantic LP Immunocore Holdings PLC [2022-07-21] 11.5
Cross Nicholas John Immunocore Holdings PLC [2022-03-17] 5.4
Laing Ian Michael Immunocore Holdings PLC [2022-02-18] 5.4
Eli Lilly & Co Immunocore Holdings PLC [2022-02-10] 5.8
Malin Life Sciences Holdings Ltd Immunocore Holdings PLC [2021-10-15] 5.39
Baker Bros Advisors LP Immunocore Holdings PLC [2021-05-20] 7.7
Rock Springs Capital Management LP Immunocore Holdings PLC [2021-04-19] 5.32
Baker Bros Advisors LP Immunocore Holdings PLC [2021-02-16] 7.5
Immunocore Ltd Adaptimmune Therapeutics PLC [2016-04-13] 6.4
Form 3/4/5 Filer 2011 - 2026
Immunocore Ltd
Ratcliffe Peter John
Pao William
Peterson Kristine
Bell John Irving
Kaul Siddharth
Herbst Roy Steven
St Leger Tina Amber
Coy Travis Alan
Jallal Bahija
Goll John
Berman David M
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Baker Bros Advisors LP
Krishana Ranjeev
Di Donato Brian
Perez Robert J
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Berman David M
Ordinary Shares
2026-02-18 Sell 5,965 $32.35 192,968
St Leger Tina Amber
Ordinary Shares
2026-02-18 Sell 1,000 $32.35 32,350
Goll John
Ordinary Shares
2026-02-18 Sell 698 $32.35 22,580
Jallal Bahija
Ordinary Shares
2026-02-18 Sell 11,474 $32.35 371,184
Jallal Bahija
Ordinary Shares
2026-02-17 Option exercise 23,817 $0.00
St Leger Tina Amber
Ordinary Shares
2026-02-17 Option exercise 2,119 $0.00
St Leger Tina Amber
Restricted Share Units · derivative
2026-02-17 Option exercise 2,119 $0.00
Berman David M
Restricted Share Units · derivative
2026-02-17 Option exercise 11,824 $0.00
Goll John
Ordinary Shares
2026-02-17 Option exercise 1,351 $0.00
Berman David M
Ordinary Shares
2026-02-17 Option exercise 11,824 $0.00
Coy Travis Alan
Employee Share Option (Right to Buy) · derivative
2026-02-17 Grant 95,637 $0.00
Coy Travis Alan
Restricted Share Units · derivative
2026-02-17 Grant 33,353 $0.00
Jallal Bahija
Restricted Share Units · derivative
2026-02-17 Option exercise 23,817 $0.00
Jallal Bahija
Restricted Share Units · derivative
2026-02-17 Grant 88,573 $0.00
Jallal Bahija
Employee Share Option (Right to Buy) · derivative
2026-02-17 Grant 395,066 $0.00
Goll John
Employee Share Option (Right to Buy) · derivative
2026-02-17 Grant 21,252 $0.00
Goll John
Restricted Share Units · derivative
2026-02-17 Grant 7,411 $0.00
Goll John
Restricted Share Units · derivative
2026-02-17 Option exercise 1,351 $0.00
Berman David M
Employee Share Option (Right to Buy) · derivative
2025-12-05 Option exercise 572 $0.00
Berman David M
Ordinary Shares
2025-12-05 Option exercise 572 $17.46 9,987
showing 20 of 112 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 144 50,948,088
2025-12-31 151 44,345,912
2025-09-30 135 42,969,617
2025-06-30 135 41,013,728
2025-03-31 121 38,727,322
2024-12-31 119 36,661,264
2024-09-30 132 36,858,532
2024-06-30 141 37,145,269
2024-03-31 156 39,166,493
2023-12-31 140 35,413,192
2023-09-30 128 34,317,205
2023-06-30 125 33,080,551
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 126,652 126,652
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 48,324 48,324
Commonwealth of Pennsylvania Public School Empls Retrmt SYS [2026-06-30] SOLE 39,532 39,532
Crossmark Global Holdings Inc [2026-06-30] SOLE 36,416 36,416
PSP Research LLC [2026-06-30] SOLE 0 15,141
IFP Advisors LLC [2026-06-30] SOLE 2,749 2,749
Gamma Investing LLC [2026-06-30] DFND 1,920 1,920
Trust Co [2026-06-30] SOLE 1,100 1,100
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 96
Farther Finance Advisors LLC [2026-06-30] SOLE 0 61
Webster Bank N A [2026-06-30] SOLE 51 51
Corecap Advisors LLC [2026-06-30] SOLE 0 27
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com